This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): 6F
6F is an oral apolipoprotein A-I (apoA-I) mimetic peptide. apoA-I is the major protein of HDL particles, the good cholesterol that removes excess cholesterol and other lipids from artery walls and other tissues.
6F is hoped to overcome problems with the oral peptide mimetic D-4F, which required too much drug substance for efficacy such that it was not cost effective to manufacture.
Pink Sheet Global Pharma Guidance Tracker – July 2018
Additional information available to subscribers only: